Literature DB >> 12237600

Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina.

Susan A Fiscus1, Adaora A Adimora, Michele L Funk, Victor J Schoenbach, Deborah Tristram, Wilma Lim, Ross McKinney, David Rupar, Charles Woods, Catherine Wilfert.   

Abstract

BACKGROUND: Mother-to-child transmission of HIV has decreased in industrialized countries because of widespread use of antiretroviral therapy (ART) by HIV-infected pregnant women and perhaps to increased use of elective cesarean section. We evaluated changes in the use of ART and mode of delivery among HIV positive pregnant women in North Carolina.
METHODS: We reviewed the medical records of HIV-exposed infants born in North Carolina between January 1, 1998, and December 31, 1999, who were tested for HIV DNA. These results were compared with data collected on HIV-exposed infants born from 1993 through 1997.
RESULTS: The use of combination ART increased from 1.5% in 1996 to 73% in 1999. The most common ART was zidovudine/lamivudine (39%) followed by zidovudine-lamivudine-nelfinavir (34%), although 34 combinations were used. Elective cesarean sections in the state increased significantly from 16.5% in the first half of 1998 to 49.4% in the second half of 1999. Overall transmission rates declined from 24.5% in 1993 to an average of 10.6% in 1994 to 1996 (41 of 385) and to 3.5% in 1997 to 1999 (15 of 428).
CONCLUSIONS: Increased use of combination ART and elective cesarean section was accompanied by consistently low rates of perinatal transmission. However, because perinatal transmission rates were also low among women who used combination therapy and had vaginal deliveries, it is difficult to determine how much additional benefit cesarean section affords. Most HIV transmission occurred among women who lacked prenatal care and did not receive or adhere to ART.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237600     DOI: 10.1097/00006454-200207000-00012

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  Fertility desires and intentions of HIV-positive patients at a suburban specialist center.

Authors:  Olufemi T Oladapo; Olusoji J Daniel; Okanlawon L Odusoga; Oluwafayokemi Ayoola-Sotubo
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

2.  Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.

Authors:  S Palmer; V Boltz; N Martinson; F Maldarelli; G Gray; J McIntyre; J Mellors; L Morris; J Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

3.  Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection.

Authors:  Susan A Fiscus; Jeffrey Wiener; Elaine J Abrams; Marc Bulterys; Ada Cachafeiro; Richard A Respess
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

Review 4.  Treatment of HIV infection in pregnant women: antiretroviral management options.

Authors:  Mona R Loutfy; Sharon L Walmsley
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Trends in perinatal HIV prevention in New York City, 1994-2003.

Authors:  Vicki B Peters; Kai-Lih Liu; Lisa-Gaye Robinson; Kenneth L Dominguez; Elaine J Abrams; Balwant S Gill; Pauline A Thomas
Journal:  Am J Public Health       Date:  2008-02-28       Impact factor: 9.308

6.  Human immunodeficiency virus-1 and preconception care.

Authors:  Margaret A Lampe
Journal:  Matern Child Health J       Date:  2006-07-11

7.  Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.

Authors:  Marie-Louise Newell; Sharon Huang; Simona Fiore; Claire Thorne; Laurent Mandelbrot; John L Sullivan; Robert Maupin; Isaac Delke; D Heather Watts; Richard D Gelber; Coleen K Cunningham
Journal:  BMC Infect Dis       Date:  2007-06-20       Impact factor: 3.090

8.  Perception on prevention of mother-to-child-transmission (PMTCT) of HIV among women of reproductive age group in Osogbo, Southwestern Nigeria.

Authors:  Ai Olugbenga-Bello; Wo Adebimpe; Ff Osundina; St Abdulsalam
Journal:  Int J Womens Health       Date:  2013-07-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.